Research Bridge is a global innovation intermediary, dedicated to identifying, evaluating, and commercialising promising academic research projects with high commercial potential. We bridge academia, investors, and industry by curating vetted research projects, securing exclusive commercialisation rights through university partnerships, and presenting them to investors seeking early access to breakthrough technologies and startups.
PhD researchers lack resources, networks, and business expertise to commercialise their innovations. Valuable research often remains confined to academic journals.
Identifying commercially viable academic research is time-consuming, fragmented across global institutions, and involves complex IP negotiations.
Technology transfer offices are under-resourced and struggle to market early-stage research effectively.
Global scouting network to identify promising PhD projects across 50+ disciplines
Proprietary evaluation algorithm assessing commercial potential, technical feasibility, and market readiness
Initial screening by domain-expert advisory board
Negotiate exclusive option agreements with universities/researchers
Establish clear IP frameworks and commercialisation rights
Prepare standardised investment packages
Curated presentation to qualified investor network
Structured investment vehicles for research funding
Ongoing management of investor-researcher relationships
Cardiologist & Industry Advisor
With over 33 years in clinical cardiology, Dr. Maltz bridges patient care, research, and commercialization. As the founder and managing director of a leading Harley Street clinic, he has successfully sourced, integrated, and scaled new medical technologies into his practice, turning clinical insight into profitable, patient-impacting businesses. His expertise ensures our projects are sound, and viable. He understands precisely how to translate breakthrough science into real-world adoption and revenue.
Academic Insight & Research Liaison
A recent graduate in biomedical chemistry, Aoki
bridges the gap between the lab bench and the boardroom. As a recent graduate at the forefront of biomedical chemistry, she has worked firsthand on groundbreaking projects, from designing novel drugs to engineering targeted therapeutics. Her first-hand understanding of the modern research frontier allow her to spot young, high-potential technology before it enters the mainstream, ensuring we identify tomorrow’s breakthroughs at their very genesis.
Our mission is to transform the world’s most promising PhD research into tangible impact. We bridge the critical gap between academic discovery and commercial application by systematically connecting breakthrough innovations with the strategic capital needed to bring them to life.
By securing exclusive pathways from lab to market and empowering researchers while providing investors with first access to tomorrow’s technologies, we fuel a self-sustaining cycle of progress. We believe the brightest ideas shouldn’t stay in journals; they should shape industries, advance society, and define the future.
Fueled by a passion for innovation and excellence, we aim to provide unparalleled opportunities that meet the unique needs of businesses and investors, fostering growth and long-term success in today’s competitive landscape.